NCT01532882View on ClinicalTrials.gov

Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs

PHASE3CompletedINTERVENTIONAL

Enrollment

378

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions

Chronic Venous Disease of Lower Limbs

Interventions

DRUG

Diosmin

tablet, 600mg, PO, 1 tab per day during 28 days

DRUG

Placebo

tablet, PO, 1 per day during 28 days

Trial Locations (1)

06000

Dr Jean-Jérôme GUEX, Nice

All Listed Sponsors

lead

Laboratoire Innotech International

INDUSTRY

NCT01532882 - Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs | Biotech Hunter | Biotech Hunter